BDSX Q2 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$138M

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$4M-31.3% YoY

Gross Profit

$2M55.8% margin

Operating Income

-$6M-132.6% margin

Net Income

-$8M-195.0% margin

EPS (Diluted)

$-0.18

QoQ Revenue Growth

-16.8%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$55,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$66M

Stockholders' Equity

-$21M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$6M	-31.3%
Gross Profit	$2M	$5M	-50.7%
Operating Income	-$6M	-$6M	+5.4%
Net Income	-$8M	-$7M	-13.2%